EcoDrugPlus

Farnesyltransferase, Caax Box, Alpha

Ensembl ID : ENSORLG00000009586
Gene Symbol: FNTA
4 Cross references
221 Possible Orthologues:

Farnesyltransferase, Caax Box, Beta

Ensembl ID : ENSORLG00000010827
Gene Symbol: FNTB
4 Cross references
209 Possible Orthologues:

Fibroblast Growth Factor Receptor 1a

Ensembl ID : ENSORLG00000014206
Gene Symbol: FGFR1A
3 Cross references
209 Possible Orthologues:

Fibroblast Growth Factor Receptor 1b

Ensembl ID : ENSORLG00000000321
Gene Symbol: FGFR1B
3 Cross references
204 Possible Orthologues:

Fibroblast Growth Factor Receptor 2

Ensembl ID : ENSORLG00000013277
Gene Symbol: FGFR2
4 Cross references
214 Possible Orthologues:

Fibroblast Growth Factor Receptor 3

Ensembl ID : ENSORLG00000017972
Gene Symbol: FGFR3
4 Cross references
193 Possible Orthologues:

Fms Related Receptor Tyrosine Kinase 1

Ensembl ID : ENSORLG00000008730
Gene Symbol: FLT1
4 Cross references
198 Possible Orthologues:

Fms Related Receptor Tyrosine Kinase 4

Ensembl ID : ENSORLG00000006599
Gene Symbol: FLT4
3 Cross references
193 Possible Orthologues:

Folate Receptor

Ensembl ID : ENSORLG00000011195
Gene Symbol: FOLR
4 Cross references
436 Possible Orthologues:

Follicle Stimulating Hormone Receptor

Ensembl ID : ENSORLG00000010178
Gene Symbol: FSHR
3 Cross references
200 Possible Orthologues:

Free Fatty Acid Receptor 2-Like

Ensembl ID : ENSORLG00000026442
Gene Symbol: LOC101169730
3 Cross references
332 Possible Orthologues:

Fyn Related Src Family Tyrosine Kinase

Ensembl ID : ENSORLG00000017982
Gene Symbol: FRK
4 Cross references
202 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).